---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002074"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2025-04-01T23:59:59+00:00"
generated_at: "2026-05-24T01:08:38.750483+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical shareholders approve reverse split; CEO Michelle Berrey and multiple directors resign

## Summary
- CEO Michelle Berrey resigned; also resigned as director along with Jack Elias, Bill Owens, Suren Ajjarapu, Amy Griffith.
- Stockholders approved reverse stock split in range of 1:2 to 1:250 (43.7M for, 15.8M against).
- Elected directors: Chirinjeev Kathuria (28.5M for), Elizabeth Ng (30.3M), Jonathan Kurtis (30.6M), Michael Peterson (30.5M).
- 2025 Equity Compensation Plan approved (28.8M for, 4.1M against).
- Non-binding say-on-pay frequency set to three years (27.2M for three years, 3.2M for two, 1.8M for one).

## SEC filing metadata
- accession: 0001641172-25-002074
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2025-04-01T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000164117225002074/0001641172-25-002074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000164117225002074/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002074
- JSON: https://secwatch.observer/filing/0001641172-25-002074.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.